Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
Granted 7 May 2013 · 2 office actions
Assignee: Novartis
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Jiahao Zhu, Yatindra Joshi, Robert F Wagner, Madhusudhan Pudipeddi +3 · Examiner: Ernst Arnold · AU 1613 · TC 1600
Life of the patent
11 dated eventsAbstract
Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
Claims
7 · 1 independent · depth 3Classifications
12 codes- A61P9/04
- A61P9/12
- A61P9/10
- A61K9/28
- A61P9/00
- A61K31/549
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
2 priority documents›Priority documents — 2
| Type | Document | Date |
|---|---|---|
| provisional | US 60805883 | 27 Jun 2006 |
| related publication | US 20120164218 A1 | 28 Jun 2012 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock